Thermo Fisher Scientific said Tuesday it is buying Solventum’s purification and filtration business, confirming an earlier ...

Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration ...

Waltham-based Thermo is buying the business from Solventum, a Minnesota-based company that spun off from manufacturing ...

Solventum (NYSE: SOLV) today announced it has entered into a definitive agreement to sell its Purification & Filtration1 ...

Thermo Fisher Scientific agreed to pay about $4.1 billion in cash to acquire Solventum’s purification and filtration business ...

Thermo Fisher Scientific today announced plans to acquire Solventum's Purification and Filtration business for $4.1 billion ...

On the heels of a move to reduce its viral vector manufacturing workforce, Thermo Fisher is beefing up its biologics ...

Shares in Solventum rallied after Thermo Fisher Scientific said it would buy the healthcare company's purification and filtration business for about $4.1 billion. Solventum was spun off from 3M last ...

Thermo Fisher Scientific agreed to acquire Solventum's purification and filtration business for $4.1 billion in cash, confirming a report first made in The Wall Street Journal.

M health care spinoff Solventum says it will sell the business unit to Massachusetts-based Thermo Fisher Scientific Inc.

Atmus Filtration Technologies公布2024年第四季度业绩强劲,每股收益 (EPS)达到0.58美元,超过预期的0.48美元。公司收入也超出预期,达到4.07亿美元,高于预期的3.977亿美元。尽管业绩向好,但股价仍下跌2.48%,收于39.18美元。